CAMBRIDGE, Mass., Jan. 3 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that it will webcast its corporate presentation at the 25th Annual JPMorgan Healthcare Conference in San Francisco, California. Joshua Boger, Ph.D., Vertex's President and Chief Executive Officer, will deliver the presentation on Tuesday, January 9, 2007 at 2:00 p.m. PST (5:00 p.m. EST).
The presentation will be webcast live and may be accessed from the 'Events Calendar' of Vertex's website at http://www.vrtx.com/. A replay of the webcast will also be available on the Company's website until January 23, 2007. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at http://www.vrtx.com/.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
DATASOURCE: Vertex Pharmaceuticals Incorporated CONTACT: Lora Pike, Manager, Investor Relations of Vertex Pharmaceuticals Incorporated, +1-617-444-6755 Web site: http://www.vrtx.com/ Company News On-Call: http://www.prnewswire.com/comp/938395.html
|